Richard Létourneau
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 7
- Pancreatic and Hepatic Oncology Research 7
- Cancer Immunotherapy and Biomarkers 4
- Cancer Treatment and Pharmacology 3
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Cancer Research top 10%
-
- Renal cell carcinoma treatment 3
-
- Neuroendocrine Tumor Research Advances 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Co-authors
- Alejandro D. RicartHarpreet WasanPeter C. TraskSinil KimPaul BycottHerbert I. HurwitzManuel ModianoN. Simon Tchekmedyian
- Cited by
- OncologyHepatologyCancer Research
- Journals
- The Lancet (1 paper)Journal of Clinical Oncology (8 papers)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- CanadaUnited StatesBelgium
In The Last Decade
Richard Létourneau
24 papers receiving 989 citations
Peers
Comparison fields: 5 of 69
- Oncology 764
- Hepatology 166
- Cancer Research 286
- Pulmonary and Respiratory Medicine 280
- Epidemiology 239
Countries citing papers authored by Richard Létourneau
This map shows the geographic impact of Richard Létourneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Létourneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Létourneau more than expected).
Fields of papers citing papers by Richard Létourneau
This network shows the impact of papers produced by Richard Létourneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Létourneau. The network helps show where Richard Létourneau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard Létourneau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 10 | |
| 4 | 2021 | 4 | |
| 5 | 2020 | 33 | |
| 6 | 2019 | 6 | |
| 7 | 2018 | 15 | |
| 8 | 2018 | 8 | |
| 9 | 2018 | 1 | |
| 10 | 2016 | 16 | |
| 11 | 2015 | 0 | |
| 12 | 2014 | 8 | |
| 13 | 2011 | 25 | |
| 14 | 2011 | 322 | |
| 15 | 2009 | 15 | |
| 16 | 2008 | 204 | |
| 17 | 2008 | 2 | |
| 18 | 2007 | 11 | |
| 19 | 2006 | 227 | |
| 20 | 2004 | 9 |
About Richard Létourneau
Richard Létourneau is a scholar working on Hepatology, Oncology and Physiology, having authored 26 papers that have together received 1.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Pancreatic and Hepatic Oncology Research (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Renal cell carcinoma treatment (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Oncology (764 citations), Hepatology (166 citations) and Cancer Research (286 citations). Richard Létourneau has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Alejandro D. Ricart, Harpreet Wasan, Peter C. Trask, Sinil Kim, Paul Bycott, Herbert I. Hurwitz, Manuel Modiano, N. Simon Tchekmedyian, Ghassan K. Abou‐Alfa and Eileen M. O’Reilly. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.